Clinical Trial Update: Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating the role of immunoglobulin G genetic variation in individuals with Alpha-1 antitrypsin deficiency and chronic obstructive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency
• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Alpha 1-Antitrypsin, COPD | Phase 4 | Status: RECRUITING